Can Irisin be a New Agent Responsible for the Development of Heart Attack and Cardiac Cachexia?
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2016, Vol 3, Issue 2
Abstract
Cardiac cachexia, a syndrome characterized by systemic destruction, nutritional impairment and weight loss [1], has a prevalence ranging between 8 and 42% around the world [2]. The syndrome was first described by the father of medicine, Hippocrates, as follows: “the flesh is consumed and becomes water; shoulders, clavicles, chest and thighs melt away. The illness is fatal” [3]. Currently the most widely accepted description of primary cachexia is, in the presence of congestive heart failure, nonvoluntary loss of >6% of non-edematous body weight in less than 6 months [1,3,4].
Authors and Affiliations
Suna Aydin
Keywords
Related Articles
- EP ID EP231610
- DOI 10.17352/2455-2976.000033
- Views 82
- Downloads 0
Numerical Analysis of Arterial Plaque Thickness and its Impact on Artery Wall Compliance
A numerical analysis was completed on the influence of plaque on the compliance of an artery wall. The analysis allowed a systematic variation of the transluminal pressure difference and plaque thickness. Included in the...
MINI-OPCABG an option in Hybrid coronary revascularization
Hybrid coronary revascularization (HCR) combines minimally invasive left internal mammary artery to left anterior descending bypass with percutaneous coronary intervention of non-left anterior descending vessels. And it...
Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
Background: We compared the angiotensin receptor–neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. Methods: In this double-...
Progression in Diagnosis and Treatment of Resistant Hypertension
Introduction: Resistant Hypertension (RH) is a major risk factor of numerous diseases. RH is a challenging clinical prob-lem,many factors affect blood pressure (BP) control. Correct diagnosis and appropriate drug therapy...
Complications of a Fenestrated Endovascular Aortic Aneurysm Repair (EVAR): A case study and first experience of National Institute of Cardiovascular Diseases Hospital, Dhaka
Endovascular aneurysm repair (EVAR) has revolutionized the therapeutic strategy for abdominal aortic aneurysm (AAA). However, hostile proximal neck and tortousity of access remain a challenge in selecting optimal stent g...